Nestlé is launching a brand new line of high-fiber, high-protein meals aimed on the rising variety of People taking Wegovy or Ozempic and others making an attempt to shed weight.
Known as Very important Pursuit meals, the merchandise are “very appropriate to help a balanced weight-reduction plan for anybody on a weight administration journey,” the Swiss meals and beverage maker mentioned Tuesday, however “are aligned in parts” for customers taking GLP-1 drugs, often known as semaglutides. Twelve newly designed meals gadgets will arrive in chosen shops nationwide in direction of the tip of this 12 months, Nestlé added.
“We all know that each shopper on a well being journey has individualized wants and issues, and having choices to fulfill these wants will proceed to play an necessary position,” Tom Moe, president of Nestlé USA's Meals Division, mentioned in a press release.
Nestlé's transfer comes as GLP-1 medicine are more and more used for weight administration and different newly found potential well being advantages. The effectiveness of medication to cut back urge for food has generated meals retailers concern who concern the drugs may cut back their earnings.
About 9 million People used GLP-1 drugs in 2023, in accordance with analytics agency Trilliant Well being. GLP-1 customers are anticipated to succeed in 30 million by 2030, in accordance with JPMorgan, which predicts the semaglutide market will surpass $100 billion that very same 12 months.